Search
for
Sort by
Research 31–60 of 112
- Polycystic Ovary Syndrome
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- An Update of Congenital Adrenal Hyperplasia
- Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
- Mixed “Antiandrogenic” Chemicals at Low Individual Doses Produce Reproductive Tract Malformations in the Male Rat
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Nonclassic congenital adrenal hyperplasia
- Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment
- Ursolic acid, a pentacyclic triterpene from Ochrosia elliptica Labill leaves and its role in the management of polycystic ovary syndrome (PCOS)
- The genetic basis of dermatophytosis skin infection susceptibility
- Depletion of S100A4+ stromal cells results in abnormal nipple development and nursing failure
- Gut–ovary axis and multiomic insights into PCOS in a DHEA-induced rat model
- Androgen excess: a hallmark of polycystic ovary syndrome
- Longitudinal clinical course in patients with 5α-reductase type 2 deficiency treated with testosterone and dihydrotestosterone during infancy and puberty
- Study on Changes of 19 Steroids in Plasma From 9 Diagnosed Patients With P450 Oxidoreductase Deficiency
- The role of hair follicles and Edar signalling in cutaneous wound healing
- Modelling androgen synthesis and action during human sexual differentiation
- Androgen biosynthetic pathways in the human prostate
- Omega-6 highly unsaturated fatty acids in Leydig cells facilitate male sex hormone production
- Delayed Diagnosis of Congenital Adrenal Hyperplasia Due to 3β-Hydroxysteroid Dehydrogenase Type 2 Deficiency
- Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts
- Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
- Genetic screening of non-classic CAH females with hyperandrogenemia identifies a novel CYP11B1 gene mutation
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Intracrine androgen biosynthesis, metabolism and action revisited
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review
- Gene variants associated with acne vulgaris presentation and severity: a systematic review and meta-analysis
- Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways